英国全国性研究中早期类风湿关节炎患者甲氨蝶呤相关不良事件的发生率与预测因素
基于英国类风湿关节炎药物研究(RAMS)前瞻性队列,纳入1069例病程≤2年、首次启用甲氨蝶呤的类风湿关节炎患者,随访1年。77.5%至少发生1种不良事件,最常见为胃肠道(42.0%)和神经系统(28.6%);女性与饮酒等基线因素与部分不良事件风险升高相关。
要点
- 首次启用甲氨蝶呤后1年内,77.5%的早期类风湿关节炎患者至少发生1种不良事件,但多数不严重。
- 最常见不良事件为胃肠道42.0%、神经系统28.6%、皮肤黏膜26.0%、肺部20.9%。
- 女性与胃肠道、皮肤黏膜、神经系统不良事件风险升高相关,饮酒与恶心、脱发、皮肤黏膜不良事件相关。
核心结论
- 甲氨蝶呤治疗第一年内不良事件常见,但多数不严重;了解不良事件发生率及相关因素有助于用药前风险沟通。
研究设计与样本
- 数据来自英国类风湿关节炎药物研究(RAMS),为前瞻性队列,纳入年龄≥18岁、医生诊断类风湿关节炎且症状持续时间≤2年、首次启用甲氨蝶呤的患者。
- 共1069例患者纳入分析,在6个月和12个月随访时通过访谈记录不良事件。
- 报告0-6个月、6-12个月和0-12个月随访期间的不良事件期间患病率,采用多变量逻辑回归评估基线特征与不良事件的关联。
主要发现
- 总体77.5%的患者至少经历1种不良事件。
- 最常见不良事件为胃肠道42.0%、神经系统28.6%、皮肤黏膜26.0%、肺部20.9%、丙氨酸转氨酶升高18.0%、血液学不良事件5.6%。
- 与不良事件风险升高相关的因素包括:女性对比男性与胃肠道、皮肤黏膜、神经系统不良事件相关;饮酒与恶心、脱发、皮肤黏膜不良事件相关。
- 年龄较大、估算肾小球滤过率较高和饮酒与血液学不良事件报告较少相关。
关键数值与推荐
- 不良事件期间患病率:0-12个月总体至少1种不良事件77.5%,胃肠道42.0%,神经系统28.6%,皮肤黏膜26.0%,肺部20.9%,丙氨酸转氨酶升高18.0%,血液学5.6%。
临床怎么用
- 了解不良事件发生率及相关因素可在启用甲氨蝶呤前用于风险沟通,帮助患者就是否开始甲氨蝶呤做出知情决定,可能提高治疗依从性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To estimate prevalence rates and identify baseline predictors of adverse events (AEs) over the first year of treatment in patients with RA starting MTX. METHODS: Data came from the UK Rheumatoid Arthritis Medication Study (RAMS), a prospective cohort of patients with RA starting MTX. This analysis included patients aged ≥18 years with physician diagnosed RA and symptom duration ≤2 years, who were commencing MTX for the first time. AEs were recorded by interviewing patients at 6- and 12-month follow-up visits. The period prevalence rates of AEs are reported for 0-6 months, 6-12 months and 0-12 months of follow-up. The associations between baseline characteristics and AEs were assessed using multivariable logistic regression. RESULTS: A total of 1069 patients were included in the analysis. Overall, 77.5% experienced at least one AE. The most commonly reported AEs were: gastrointestinal (42.0%), neurological (28.6%), mucocutaneous (26.0%), pulmonary (20.9%), elevated alanine transaminase (18.0%) and haematological AEs (5.6%). Factors associated with increased odds of AEs were: women vs men (gastrointestinal, mucocutaneous, neurological) and alcohol consumption (nausea, alopecia, mucocutaneous). Older age, higher estimated glomerular filtration rate and alcohol consumption were associated with less reporting of haematological AEs. CONCLUSIONS: AEs were common among patients over the first year of MTX, although most were not serious. Knowledge of the rates and factors associated with AE occurrence are valuable when communicating risks prior to commencing MTX. This can help patients make informed decisions whether to start MTX, potentially increasing adherence to treatment.
引用
- Sherbini AA, Gwinnutt JM, Hyrich KL, et al. Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study. Rheumatology (Oxford). 2022. PMID: 35078225. doi:10.1093/rheumatology/keab917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。